Back to User profile » Dr Yingtao Lin
Papers published by Dr Yingtao Lin:
Original Research
Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Zhou C, Wei J, Xu K, Lin Y, Zhang L, Li X
Risk Management and Healthcare Policy 2023, 16:2447-2458
Published Date: 15 November 2023
Original Research
How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study
Shang L, Lin Y, Fang W, Liu Y, Bao Y, Li X, Zhang Y
Risk Management and Healthcare Policy 2023, 16:1739-1753
Published Date: 4 September 2023
Original Research
Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Lin YT, Chen Y, Liu TX, Kuang F, Huang P
Cancer Management and Research 2021, 13:8219-8230
Published Date: 2 November 2021